Medgenics Receives $3.4M Grant From OCS

June 14, 2015 | The US-Israeli company creating novel gene-based therapies, Medgenics received a $3.4 million grant from Israel’s Office of the Chief Scientist, part of the Ministry of the Economy. According to the company, the grant will be used to cover research and development expenses over a 13 month period. Medgenics is a publicly traded company that has developed the TARGT system for the production and delivery of therapeutic proteins for the treatment of rare and orphan diseases.